These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 20480804)

  • 61. Spironolactone in the treatment of adolescent acne: A retrospective review.
    Berman HS; Cheng CE; Hogeling M
    J Am Acad Dermatol; 2021 Jul; 85(1):269-271. PubMed ID: 33253846
    [No Abstract]   [Full Text] [Related]  

  • 62. Oral Spironolactone for Acne Vulgaris in Adult Females: An Update of the Literature.
    Barker RA; Wilcox C; Layton AM
    Am J Clin Dermatol; 2020 Apr; 21(2):303-305. PubMed ID: 32166709
    [No Abstract]   [Full Text] [Related]  

  • 63. Long-term safety of spironolactone in acne: results of an 8-year followup study.
    Shaw JC; White LE
    J Cutan Med Surg; 2002; 6(6):541-5. PubMed ID: 12219252
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Adverse effects of spironolactone therapy in women with acne.
    Lubbos HG; Hasinski S; Rose LI; Pollock J
    Arch Dermatol; 1998 Sep; 134(9):1162-3. PubMed ID: 9762041
    [No Abstract]   [Full Text] [Related]  

  • 65. Spironolactone and risk of upper gastrointestinal events: spironolactone may not be guilty.
    Campbell E; Shonde A; Foley S
    BMJ; 2006 Sep; 333(7566):500; author reply 500-1. PubMed ID: 16946346
    [No Abstract]   [Full Text] [Related]  

  • 66. The Safe Management of Acne Vulgaris in Lupus Erythematosus: A Systematic Review with Evidence-Based Treatment Recommendations.
    Forouzandeh M; Maderal AD
    Am J Clin Dermatol; 2020 Feb; 21(1):13-20. PubMed ID: 31494859
    [TBL] [Abstract][Full Text] [Related]  

  • 67. A matched cohort study evaluating whether spironolactone or tetracycline-class antibiotic use among female acne patients is associated with breast cancer development risk.
    Garate D; Thang CJ; Golovko G; Wilkerson MG; Barbieri JS
    Arch Dermatol Res; 2024 May; 316(5):196. PubMed ID: 38775970
    [No Abstract]   [Full Text] [Related]  

  • 68. Why and when the treatment of acne fails. What to do.
    Katsambas AD
    Dermatology; 1998; 196(1):158-61. PubMed ID: 9557252
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Anti-androgenic therapy using oral spironolactone for acne vulgaris in Asians.
    Sato K; Matsumoto D; Iizuka F; Aiba-Kojima E; Watanabe-Ono A; Suga H; Inoue K; Gonda K; Yoshimura K
    Aesthetic Plast Surg; 2006; 30(6):689-94. PubMed ID: 17077951
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Spironolactone and risk of upper gastrointestinal events: association is unproved.
    Dawwas MF
    BMJ; 2006 Sep; 333(7566):501. PubMed ID: 16946352
    [No Abstract]   [Full Text] [Related]  

  • 71. Spironolactone and risk of upper gastrointestinal events: causality remains unconvincing.
    Jones GP
    BMJ; 2006 Sep; 333(7566):501. PubMed ID: 16946351
    [No Abstract]   [Full Text] [Related]  

  • 72. Use of spironolactone for the treatment of acne in adolescent girls.
    Canu D; Mary-Prey S; Legrand A; Leauté-Labreze C
    Ann Dermatol Venereol; 2024 Jun; 151(2):103281. PubMed ID: 38781891
    [No Abstract]   [Full Text] [Related]  

  • 73. What do we know about prescribing spironolactone for acne?
    Santer M; Layton A
    BMJ; 2023 May; 381():1114. PubMed ID: 37197774
    [No Abstract]   [Full Text] [Related]  

  • 74. K+larity for Spironolactone: At Last!
    Graber EM
    JAMA Dermatol; 2015 Sep; 151(9):926-7. PubMed ID: 25796224
    [No Abstract]   [Full Text] [Related]  

  • 75. What your doctor is reading.
    Clark W
    Diabetes Self Manag; 2011; 28(4):49-50, 52-4. PubMed ID: 21848054
    [No Abstract]   [Full Text] [Related]  

  • 76. Effectiveness of spironolactone for women with acne vulgaris (SAFA) trial: a critically appraised topic.
    Shields A; Barbieri JS
    Br J Dermatol; 2023 Oct; 189(5):509-510. PubMed ID: 37503674
    [No Abstract]   [Full Text] [Related]  

  • 77. Spironolactone for acne in women.
    Drug Ther Bull; 2023 Sep; 61(9):132. PubMed ID: 37468231
    [No Abstract]   [Full Text] [Related]  

  • 78. Use of spironolactone to treat acne in adolescent females.
    Roberts EE; Nowsheen S; Davis DMR; Hand JL; Tollefson MM; Wetter DA
    Pediatr Dermatol; 2021 Jan; 38(1):72-76. PubMed ID: 33009838
    [TBL] [Abstract][Full Text] [Related]  

  • 79. A unique case of buffalo hump after prolonged use of spironolactone.
    Hudd TR; Chugh P; Zaiken K
    J Am Pharm Assoc (2003); 2018; 58(6):679-681. PubMed ID: 30219491
    [No Abstract]   [Full Text] [Related]  

  • 80. Trends in the prescribing pattern of spironolactone for acne and hidradenitis suppurativa in adolescents.
    Horissian M; Maczuga S; Barbieri JS; Zaenglein AL
    J Am Acad Dermatol; 2022 Sep; 87(3):684-686. PubMed ID: 34896127
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.